Deciphering protein aggregation in freeze-thaw process: the roles of cold denaturation and shear stress

• A precise downscale model using 10 mL vials was developed to help mimic freeze–thaw protein aggregation manufacturing-scale containers. • Cold denaturation was suggested to be an important contributing factor in protein aggregation during freeze–thaw. • Protein aggregation increased when the heat transfer geometry allowed ice to enclose the liquid phase, which may be related to higher freezing pressure-induced mechanical stresses. Understanding protein aggregation during freeze–thaw is vital for biopharmaceutical quality assurance. This study investigates monoclonal antibody aggregation linked to stress-time, the time a formulation remains partly frozen above glass transition temperature of the freeze concentrate (T g ’). Stress–time distributions of a 0.5 L bottle were implemented in 10 mL vials by controlling ice-nucleation, cooling, and heating rates. These vials were used as downscale models to explore cold denaturation, by varying times under temperatures from −5 °C to T g ’. Matching stress-times between scales resulted in similar aggregation levels. However, extending the stress-time in a low cold denaturation range (−5 °C to freezing equilibrium temperature (T f )) did not significantly increase aggregation, suggesting its critical role in freeze–thaw stability. Aggregation in vials was about 1/3 lower than in bottles, apparently related to the vials’ bottom-up freezing geometry, which does not enclose unfrozen liquid within the ice. Imposing a similar geometry on the bottle, using top insulation, aligning aggregation levels, suggesting the contribution of shear stress from ice interface percolation. Overall, a 5.5 mL sample (in a 10 mL vial) may serve as a model for larger volumes by accurately controlling heat transfer rates with the assistance of computational fluid dynamics. This approach provides supporting evidence and a step toward improving understanding of biopharmaceutical ‘sensitivity’ to freeze–thaw stresses.

Authors

Institutions

Publication Details

Journal
European Journal of Pharmaceutics and Biopharmaceutics
Published
2025-10-25
DOI
https://doi.org/10.1016/j.ejpb.2025.114905
Citations
2
Primary Topic
Freezing and Crystallization Processes
Type
article
Field-Weighted Citation Impact
1.73
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Deciphering protein aggregation in freeze-thaw process: the roles of cold denaturation and shear stress

Klara Gries, Rogério Coutinho das Neves, Michael Schupfner, Sebastian Andris et al.
2 citations
European Journal of Pharmaceutics and Biopharmaceutics
Freezing and Crystallization Processes
1.73
article

Deciphering protein aggregation in freeze-thaw process: the roles of cold denaturation and shear stress

Klara Gries, Rogério Coutinho das Neves, Michael Schupfner, Sebastian Andris, Miguel Â. Rodrigues, Andreia Duarte, Vı́tor Geraldes
article en
2 citations

Abstract

• A precise downscale model using 10 mL vials was developed to help mimic freeze–thaw protein aggregation manufacturing-scale containers. • Cold denaturation was suggested to be an important contributing factor in protein aggregation during freeze–thaw. • Protein aggregation increased when the heat transfer geometry allowed ice to enclose the liquid phase, which may be related to higher freezing pressure-induced mechanical stresses. Understanding protein aggregation during freeze–thaw is vital for biopharmaceutical quality assurance. This study investigates monoclonal antibody aggregation linked to stress-time, the time a formulation remains partly frozen above glass transition temperature of the freeze concentrate (T g ’). Stress–time distributions of a 0.5 L bottle were implemented in 10 mL vials by controlling ice-nucleation, cooling, and heating rates. These vials were used as downscale models to explore cold denaturation, by varying times under temperatures from −5 °C to T g ’. Matching stress-times between scales resulted in similar aggregation levels. However, extending the stress-time in a low cold denaturation range (−5 °C to freezing equilibrium temperature (T f )) did not significantly increase aggregation, suggesting its critical role in freeze–thaw stability. Aggregation in vials was about 1/3 lower than in bottles, apparently related to the vials’ bottom-up freezing geometry, which does not enclose unfrozen liquid within the ice. Imposing a similar geometry on the bottle, using top insulation, aligning aggregation levels, suggesting the contribution of shear stress from ice interface percolation. Overall, a 5.5 mL sample (in a 10 mL vial) may serve as a model for larger volumes by accurately controlling heat transfer rates with the assistance of computational fluid dynamics. This approach provides supporting evidence and a step toward improving understanding of biopharmaceutical ‘sensitivity’ to freeze–thaw stresses.

European Journal of Pharmaceutics and BiopharmaceuticsVol. 217
Boehringer Ingelheim (Germany) (DE), University of Lisbon (PT), Ciência Viva (PT)
Openalex Percentile: Top 14%
Freezing and Crystallization Processes
1.73
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.